MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET 2019-2027


MARKET OUTLOOK
Triton Market Research's report on the injectable drug delivery market in the Middle East and Africa estimates the industry to grow at a CAGR of 11.04% during the forecast period 2019-2027.
Turkey, the United Arab Emirates, Saudi Arabia and the Rest of the Middle East & Africa are the countries studied in the Middle East & Africa injectable drug delivery market.
The increasing chronic diseases, technological developments in drug technology and the growing pharmaceutical industry are the key factors driving the market growth in the Middle East and Africa. There is a steady increase in the elderly population in Middle Eastern countries like Saudi Arabia and Turkey. The rising geriatric population, along with the increasing prevalence of cardiovascular diseases, is driving the market growth in these countries. 
With the health awareness programs on HIV and TB being conducted successfully, there is a decline in the mortality rate in South Africa and thereby increasing the life expectancy. According to the World Health Organization (WHO), there is an increase in cancer patients in the country. If no action is taken, these numbers are expected to rise further and will probably lead to the market growth of injectable drug delivery.
The increasing occurrence of AIDS, Alzheimer's and arthritis have led to the demand for new bioactive elements in Rest of the Middle East & Africa. This factor has increased the demand for injectable drug delivery technology in this region. Several strategic initiatives have been planned in the region to encourage emerging technology.
COMPETITIVE OUTLOOK
The significant players in the injectable drug delivery market are GERRESHEIMER, INJEX, Novartis AG, Novo Nordis A/S, Elcam Medical, Eli Lilly and Company, Pfizer Inc and SANOFI.
TABLE OF CONTENT 
1. MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITIONS
2.2. PORTER'S FIVE FORCES MODEL
2.2.1. THREAT OF NEW ENTRANT
2.2.2. THREAT OF SUBSTITUTE
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. INTENSITY OF COMPETITIVE RIVALRY
2.3. MARKET SHARE OUTLOOK
2.4. KEY INSIGHT
2.5. KEY BUYING CRITERIA
2.6. LEGAL REQUIREMENT
2.7. MARKET ATTRACTIVENESS INDEX
2.8. MARKET DRIVERS
2.8.1. INCREASING GERIATRIC POPULATION
2.8.2. TECHNOLOGICAL ADVANCEMENT
2.8.3. GROWING OCCURRENCE OF AUTOIMMUNE DISEASES
2.9. MARKET RESTRAINT
2.9.1. HIGH MANUFACTURING COST OF THE INJECTABLE DRUG DELIVERY
2.10. MARKET OPPORTUNITY
2.10.1. DEVELOPMENT OF BETTER INJECTABLE SYSTEMS
2.11. MARKET CHALLENGES
2.11.1. DEVELOPMENTS IN THE ALTERNATE DRUG DELIVERY SYSTEM
2.11.2. STRINGENT REGULATIONS
3. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY DEVICE TYPE
3.1. PEN INJECTOR
3.2. AUTO?INJECTOR
3.3. NEEDLE-FREE INJECTOR
3.4. PREFILLED SYRINGE
4. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION
4.1. SUBCUTANEOUS
4.2. INTRAMUSCULAR
4.3. INTRAVENOUS (IV)
4.4. OTHER ROUTE OF ADMINISTRATION
5. INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY END-USER
5.1. CLINICS/ PHYSICIAN OFFICES
5.2. AMBULATORY CARE
5.3. HOSPITAL
5.4. HOME BASED
5.5. OTHERS END-USER
6. INJECTABLE DRUG DELIVERY MARKET – MIDDLE EAST AND AFRICA
6.1. COUNTRY ANALYSIS
6.1.1. SAUDI ARABIA
6.1.2. TURKEY
6.1.3. UNITED ARAB EMIRATES
6.1.4. SOUTH AFRICA
6.1.5. REST OF MIDDLE EAST & AFRICA
7. COMPANY PROFILES
7.1. BAXTER 
7.2. BECTON, DICKINSON AND COMPANY (BD)
7.3. ELCAM MEDICAL
7.4. ELI LILLY AND COMPANY
7.5. GERRESHEIMER 
7.6. INJEX 
7.7. NOVARTIS AG
7.8. NOVO NORDISK A/S
7.9. PFIZER INC
7.10. SANOFI
7.11. SCHOTT AG
7.12. TERUMO CORPORATION
7.13. TEVA PHARMACEUTICAL INDUSTRIES LTD
7.14. WEST PHARMACEUTICAL SERVICES INC
7.15. YPSOMED
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS
 
 
LIST OF TABLES 
TABLE 1  MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
TABLE 2  MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2027 ($ MILLION) 
TABLE 3  DIFFERENT TYPES OF INSULIN PEN INJECTORS 
TABLE 4  MARKETED NEEDLE-FREE INJECTORS PRODUCTS 
TABLE 5  LYOPHILIZED DRUGS WHICH ARE USED IN PREFILLED SYRINGE 
TABLE 6  MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) 
TABLE 7  MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) 
TABLE 8  MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION) 
LIST OF FIGURES 
FIGURE 1 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 2 COMPANY MARKET SHARE OUTLOOK 2017 (%) 
FIGURE 3 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY PEN INJECTOR, 2019-2027 ($ MILLION) 
FIGURE 4 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY AUTO?INJECTOR, 2019-2027 ($ MILLION) 
FIGURE 5 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY NEEDLE-FREE INJECTOR, 2019-2027 ($ MILLION) 
FIGURE 6 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY PREFILLED, 2019-2027 ($ MILLION) 
FIGURE 7 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY SUBCUTANEOUS, 2019-2027 ($ MILLION) 
FIGURE 8 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY INTRAMUSCULAR, 2019-2027 ($ MILLION) 
FIGURE 9 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY INTRAVENOUS, 2019-2027 ($ MILLION)  
FIGURE 10 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY OTHER ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) 
FIGURE 11 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY CLINICS/ PHYSICIAN OFFICES, 2019-2027 ($ MILLION)  
FIGURE 12 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY AMBULATORY CARE, 2019-2027 ($ MILLION) 
FIGURE 13 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY HOSPITAL, 2019-2027 ($ MILLION) 
FIGURE 14 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY HOME BASED, 2019-2027 ($ MILLION) 
FIGURE 15 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY OTHER END-USER, 2019-2027 ($ MILLION) 
FIGURE 16 SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 17 TURKEY INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 18 UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 19 SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) 
FIGURE 20 REST OF MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION)

LIST OF TABLES TABLE 1 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) TABLE 2 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2027 ($ MILLION) TABLE 3 DIFFERENT TYPES OF INSULIN PEN INJECTORS TABLE 4 MARKETED NEEDLE-FREE INJECTORS PRODUCTS TABLE 5 LYOPHILIZED DRUGS WHICH ARE USED IN PREFILLED SYRINGE TABLE 6 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) TABLE 7 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) TABLE 8 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION) LIST OF FIGURES FIGURE 1 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 2 COMPANY MARKET SHARE OUTLOOK 2017 (%) FIGURE 3 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY PEN INJECTOR, 2019-2027 ($ MILLION) FIGURE 4 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY AUTO?INJECTOR, 2019-2027 ($ MILLION) FIGURE 5 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY NEEDLE-FREE INJECTOR, 2019-2027 ($ MILLION) FIGURE 6 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY PREFILLED, 2019-2027 ($ MILLION) FIGURE 7 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY SUBCUTANEOUS, 2019-2027 ($ MILLION) FIGURE 8 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY INTRAMUSCULAR, 2019-2027 ($ MILLION) FIGURE 9 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY INTRAVENOUS, 2019-2027 ($ MILLION) FIGURE 10 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY OTHER ROUTE OF ADMINISTRATION, 2019-2027 ($ MILLION) FIGURE 11 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY CLINICS/ PHYSICIAN OFFICES, 2019-2027 ($ MILLION) FIGURE 12 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY AMBULATORY CARE, 2019-2027 ($ MILLION) FIGURE 13 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY HOSPITAL, 2019-2027 ($ MILLION) FIGURE 14 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY HOME BASED, 2019-2027 ($ MILLION) FIGURE 15 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY OTHER END-USER, 2019-2027 ($ MILLION) FIGURE 16 SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 17 TURKEY INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 18 UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 19 SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION) FIGURE 20 REST OF MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET, 2019-2027 ($ MILLION)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by Triton Market Research

GLOBAL RECYCLED GLASS MARKET 2020-2028

MARKET OUTLOOK According to Triton, the global recycled glass market is expected to display a positive market trend over the forecast years 2020-2028, exhibiting a CAGR of 6.02% (by revenue) and 6.25% (by volume). Glass has several advantageous prope...

GLOBAL PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK As per an analysis by the Triton Market Research on the global PP nonwoven market, it is estimated that the industry would show growth at a CAGR of 7.05% in the period 2020-2028. PP nonwoven material is used in the production of diaper...

NORTH AMERICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK A Triton Market Research report on the North American PP nonwoven market depicts that the market is likely to show growth at a CAGR of 6.87% in the forecast period between 2020 and 2028. The United States and Canada comprises the North...

MIDDLE EAST AND AFRICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK As per a Triton Market Research report, the PP nonwoven market in the Middle East and Africa is set to accelerate at a CAGR of 8.51% during the forecast period 2020-2028. Saudi Arabia, Turkey, the United Arab Emirates and the Rest of t...

LATIN AMERICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK A Triton Market Research report illustrates that the Latin American PP nonwoven market would exhibit a CAGR of 7.28% during the estimated period 2020-2028. Brazil, Mexico and the Rest of Latin America together form the PP nonwoven mark...

Publisher: Triton Market Research